3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
26 25 0 0 0 0 0 0 0999 V2000
3.2961 -1.3943 0.0096 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2873 1.3907 0.0102 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2590 0.7204 0.0119 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2570 -0.7218 0.0176 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5470 0.2274 0.0498 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.5441 -0.2260 0.0500 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6540 -0.3753 -0.0369 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6721 0.3903 -0.0545 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8637 0.5579 -0.0172 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8634 -0.5652 -0.0342 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1982 -0.1698 -0.0058 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1941 0.1658 -0.0003 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6881 -1.0306 0.8425 H 0 0 0 0 0 0 0 0 0 0 0 0
0.7112 -1.0295 -0.9159 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.7209 1.0261 -0.9471 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.7201 1.0591 0.8137 H 0 0 0 0 0 0 0 0 0 0 0 0
1.8201 1.1995 0.8713 H 0 0 0 0 0 0 0 0 0 0 0 0
1.8410 1.2090 -0.8996 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.8446 -1.2056 -0.9241 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.8089 -1.2131 0.8490 H 0 0 0 0 0 0 0 0 0 0 0 0
4.1296 1.7273 0.0034 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.1299 -1.7289 0.0080 H 0 0 0 0 0 0 0 0 0 0 0 0
5.9933 0.6290 0.8734 H 0 0 0 0 0 0 0 0 0 0 0 0
6.0369 0.6179 -0.7541 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.9946 -0.6264 0.8718 H 0 0 0 0 0 0 0 0 0 0 0 0
-6.0315 -0.6157 -0.7558 H 0 0 0 0 0 0 0 0 0 0 0 0
1 11 2 0 0 0 0
2 12 2 0 0 0 0
3 5 1 0 0 0 0
3 11 1 0 0 0 0
3 21 1 0 0 0 0
4 6 1 0 0 0 0
4 12 1 0 0 0 0
4 22 1 0 0 0 0
5 23 1 0 0 0 0
5 24 1 0 0 0 0
6 25 1 0 0 0 0
6 26 1 0 0 0 0
7 8 1 0 0 0 0
7 9 1 0 0 0 0
7 13 1 0 0 0 0
7 14 1 0 0 0 0
8 10 1 0 0 0 0
8 15 1 0 0 0 0
8 16 1 0 0 0 0
9 11 1 0 0 0 0
9 17 1 0 0 0 0
9 18 1 0 0 0 0
10 12 1 0 0 0 0
10 19 1 0 0 0 0
10 20 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
hexanedihydrazide
4.2 InChl
InChI=1S/C6H14N4O2/c7-9-5(11)3-1-2-4-6(12)10-8/h1-4,7-8H2,(H,9,11)(H,10,12)
4.3 InChlKey
IBVAQQYNSHJXBV-UHFFFAOYSA-N
4.4 Canonical SMILES
C(CCC(=O)NN)CC(=O)NN
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病